ArticleClinical kidney journal2026
Early identification of acute kidney injury progression in critically ill patients with sepsis: interpretable machine learning approach.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute kidney injury (AKI) is a common and severe complication of sepsis and is often associated with a poor prognosis. However, there is still a lack of an effective prediction model for early identification of AKI progression in critical septic patients, defined as AKI stage 1 or 2 to stage 3 within 7 days after diagnosis of sepsis-associated AKI (SA-AKI). Methods: We extracted the clinical data of patients with SA-AKI from the Medical Information Mart for Intensive Care (MIMIC) datasets, eICU Collaborative Research Database (eICU-CRD) and Salzburg Intensive Care database (SICdb), with the MIMIC-IV (version 3.1) database used for training and internal validation, the MIMIC-III Clinical Database CareVue subset used as temporal validation, and the eICU-CRD and SICdb used as external validation. Lasso regression and recursive feature elimination were used for feature selection. Six machine learning (ML) algorithms, including k-nearest neighbors, logistic regression, naïve Bayes, random forest (RF), support vector machine and decision tree, were utilized to establish the prediction model. Model performance was assessed using receiver operating characteristic curves, calibration curves and decision curve analysis. SHapley Additive exPlanations (SHAP) method was used for the interpretation of the models. Results: The MIMIC-IV, MIMIC-III subset, eICU-CRD and SICdb included 9193, 2178, 10 332 and 1701 patients with SA-AKI. Twelve variables were selected for model construction, including weight, liver disease, mechanical ventilation, systolic blood pressure, hemoglobin, glucose, blood urea nitrogen, creatinine, chloride, anion gap and urine output. An RF model achieved the best performance in both internal, temporal and external validation (area under the curve is 0.779, 0.758 and 0.713, respectively). A user-friendly platform was built to early predict SA-AKI progression for clinician use. Conclusion: ML could be a useful tool for predicting AKI progression in septic patients. We developed an RF model to predict the risk of SA-AKI progression, which may provide a reference for early identification and prompt intervention of high-risk group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.